ClinicalTrials.Veeva

Menu

Improving Care for Women With Urinary Incontinence (EMPOWER)

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

Urinary Incontinence

Treatments

Other: Patient Education
Other: Nurse Navigation
Other: ChatBot

Study type

Interventional

Funder types

Other

Identifiers

NCT05515198
20211420

Details and patient eligibility

About

The overall goal is to improve diagnosis and non-operative management of urinary incontinence in women.

Full description

In the study, patients will be screened in primary care offices for symptoms of urinary incontinence. Women with positive screening results will be asked if they are interested in participating in an implementation study where women will be assigned to one of the three following groups:

  1. Usual Care plus Patient Educational Opportunities - The patient's urinary incontinence will be managed using standard of care treatment by the patient's primary care provider. Patients will be offered educational opportunities about urinary incontinence.
  2. Nurse Navigation - Along with the treatment described for "Usual Care plus Patient Educational Opportunities," a nurse navigator will work with the patient to implement behavioral changes and provide education and physical therapy options. In addition, the navigator will be available to answer the patient's questions in a timely fashion and help the patient move through the care pathway.
  3. Nurse Navigation and ChatBot - Along with the treatment described for "Usual Care plus Patient Educational Opportunities" and "Nurse Navigation," this group will include a ChatBot feature which will allow a patient to directly and privately communicate with an artificial intelligence-driven ChatBot, also known as a "conversational agent," that will provide education and help the patient navigate the care pathway.

All participants will complete questionnaires throughout their enrollment and data will be collected from medical records. The study team will analyze the data at six months after the original appointment/study enrollment, assess adherence to therapy and how the therapy impacted the outcomes the team hopes to improve, such as improvement in symptoms. The study will be implemented over three subsequent time periods called Wave 1, Wave 2 and Wave 3 with primary care practices from two geographic regions being involved in each wave (6 regions total). Participants in Wave 1 will be followed for a total of 18 months, while participants in Wave 2 will be followed for a total of 12 months, and participants in Wave 3 will be followed for 6 months. Primary care providers at all participating practices will be offered educational opportunities related to urinary incontinence.

Enrollment

400 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Female patient having a primary care provider visit at University Hospitals (UH) Cleveland Primary Care Institute (PCI)
  2. ≥ 18 years old
  3. Scores 1 or higher on the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-SF)

Exclusion criteria

None

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 3 patient groups

Arm 1
Experimental group
Description:
Patient Education
Treatment:
Other: Patient Education
Arm 2
Experimental group
Description:
Patient Education + Nurse Navigation
Treatment:
Other: Nurse Navigation
Other: Patient Education
Arm 3
Experimental group
Description:
Patient Education + Nurse Navigation + ChatBot
Treatment:
Other: ChatBot
Other: Nurse Navigation
Other: Patient Education

Trial contacts and locations

1

Loading...

Central trial contact

Ellen Divoky; Elisar Khawam

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems